Eleanor Hayward

Eleanor Hayward, Health Editor at The Times, dives into the heart of the resident doctors' strike. She explores the escalating tensions between the NHS and the government, emphasizing the economic struggles faced by these essential workers. Hayward sheds light on the disparity in pay, the push for reforms, and how political maneuvering could reshape strike regulations. With over 50,000 doctors involved, she discusses the potential impact on patient care and the healthcare system at large. Don't miss her insights on the future of the NHS!

Eleanor Hayward, Health editor at The Times, and Dr. Tony Lloyd, a counselling psychologist and former CEO of the ADHD Foundation, delve into the government's independent review on mental health and ADHD services. They discuss rising diagnoses, the pressures of long waiting lists, and alarming welfare costs. Lloyd shares insights from his own late ADHD diagnosis and challenges the narrative of overdiagnosis, urging a shift towards better support for neurodiverse individuals. Together, they navigate the urgent need for systemic reform.

Eleanor Hayward, Health Editor at The Times, shares her insights on the recent COVID inquiry findings, revealing stark criticisms of Boris Johnson's government. She discusses how a one-week lockdown delay led to approximately 23,000 additional deaths and the chaotic decision-making during early 2020. Hayward highlights the clash between scientific advice and political indecision, the toxic culture within Downing Street, and the impact of confusing policies. She also acknowledges the rapid vaccine rollout as a rare success amid early failures.

Poppy Koronka, a health correspondent for The Times, and Eleanor Hayward, the health editor, delve into the controversial rise of weight loss medications like Ozempic. They discuss how social media influencers market these drugs, often targeting vulnerable audiences. The duo reveals ethical concerns surrounding unregulated prescriptions and the serious health risks faced by those misusing these medications. The podcast highlights the urgent need for regulatory interventions to tackle the alarming accessibility of these drugs for individuals who may not even need them.

It's one of the world's biggest killers but cancer is usually more associated with people in the later stages of life. While that's still largely the case, increasing numbers of younger people seem to be getting the disease. So what could be behind the rise?This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: http://thetimes.com/thestoryGuests:Molly Guinness, Times Radio Executive Producer.Eleanor Hayward, Times Health Editor.Host: Luke Jones.Clips: BBC; You, Me and the Big C.Get in touch: storiesofourtimes@thetimes.co.ukFind out more about our bonus series for Times subscribers: 'Inside the newsroom'This podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here. Hosted on Acast. See acast.com/privacy for more information.